Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference3%
- Check24 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signalling a new release with updated core content. The Back to Top element has been removed as a minor UI cleanup.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific medical terms related to penile cancer and urogenital diseases, while also removing several related terms and location details.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.